Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature

K Ghasemi Falavarjani, QD Nguyen - Eye, 2013 - nature.com
Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is increasingly
used for the treatment of a wide variety of retinal diseases, including age-related macular …

Complications of intravitreal injections: 2022

D Patel, SN Patel, V Chaudhary… - Current Opinion in …, 2022 - journals.lww.com
Intravitreal injections continue to be one of the most commonly performed procedures by
ophthalmologists. Although the injections are generally well tolerated, sight-threatening …

Systemic and ocular adverse events with intravitreal anti-VEGF therapy used in the treatment of diabetic retinopathy: a review

JA Zehden, XM Mortensen, A Reddy… - Current Diabetes Reports, 2022 - Springer
Abstract Purpose of Review Intravitreal anti-vascular endothelial growth factor (VEGF)
agents are used routinely in the management of neovascular conditions including …

Inflammatory complications of intravitreal anti-VEGF injections

JT Cox, D Eliott, L Sobrin - Journal of Clinical Medicine, 2021 - mdpi.com
Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents is a
commonly used therapy for numerous retinal diseases. The most commonly used of these …

Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review

RC Gentile, S Shukla, M Shah, DC Ritterband… - Ophthalmology, 2014 - Elsevier
Purpose To identify the spectrum and susceptibility pattern of pathogens responsible for
culture-positive endophthalmitis referred to a single institution and investigate possible …

Microbial flora and resistance in ophthalmology: a review

A Grzybowski, P Brona, SJ Kim - Graefe's Archive for Clinical and …, 2017 - Springer
Antibiotic resistance in systemic infection is well-researched and well-publicized. Much less
information is available on the resistance of normal ocular microbiome and that of …

The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection

P Storey, M Dollin, J Pitcher, S Reddy, J Vojtko… - Ophthalmology, 2014 - Elsevier
Objective To compare the incidence of endophthalmitis after intravitreal injection with and
without topical postinjection antibiotic prophylaxis. Design Retrospective case-control study …

Clinical pattern of antibiotic overuse and misuse in primary healthcare hospitals in the southwest of China

Y Chang, S Chusri, R Sangthong, E McNeil, J Hu… - PloS one, 2019 - journals.plos.org
Purpose Overuse and misuse of antibiotics are the primary risk factors for antibiotics
resistance. Inadequate professional competence of primary care physicians might …

Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept

N Rayess, E Rahimy, P Storey, CP Shah… - American journal of …, 2016 - Elsevier
Purpose To compare the incidence and clinical outcomes of endophthalmitis following
intravitreal injections of bevacizumab, ranibizumab, and aflibercept. Design Multicenter …

Current Evidence for the Prevention of Endophthalmitis in Anti‐VEGF Intravitreal Injections

PET Lau, KS Jenkins, CJ Layton - Journal of ophthalmology, 2018 - Wiley Online Library
Intravitreal injection of a therapeutic substance is the most common procedure performed in
ophthalmology. It has a low incidence of serious complications but is associated with a small …